Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a …

L Degenhardt, P Webb, S Colledge-Frisby… - The Lancet Global …, 2023 - thelancet.com
Background People who inject drugs are exposed to various and changing risk
environments and are at risk of multiple harms related to injecting drug use (IDU). We aimed …

Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage …

L Degenhardt, A Peacock, S Colledge… - The Lancet Global …, 2017 - thelancet.com
Background Sharing of equipment used for injecting drug use (IDU) is a substantial cause of
disease burden and a contributor to blood-borne virus transmission. We did a global …

Prevalence of injecting drug use and HIV, hepatitis B, and hepatitis C in people who inject drugs in the Eastern Mediterranean region: a systematic review and meta …

AM Aghaei, J Gholami, A Sangchooli… - The Lancet Global …, 2023 - thelancet.com
Background Considerable disease burden is attributed to injecting drug use (IDU). This
regional systematic review and meta-analysis aimed to assess the prevalence of IDU and …

Severe bacterial infections in people who inject drugs: the role of injection-related tissue damage

A Hrycko, P Mateu-Gelabert, C Ciervo… - Harm Reduction …, 2022 - Springer
Background In the context of the current US injection drug use epidemic, targeted public
health harm reduction strategies have traditionally focused on overdose prevention and …

Low hepatitis C reinfection following direct-acting antiviral therapy among people who inject drugs on opioid agonist therapy

MJ Akiyama, D Lipsey, M Heo… - Clinical Infectious …, 2020 - academic.oup.com
Background Direct-acting antiviral (DAA) therapy is highly effective in people who inject
drugs (PWID); however, rates, specific injection behaviors, and social determinants …

[PDF][PDF] Recommendations for implementing hepatitis C virus care in homeless shelters: the stakeholder perspective

JK Fokuo, CL Masson, A Anderson… - Hepatology …, 2020 - Wiley Online Library
Compared with the general population, homeless individuals are at higher risk of hepatitis C
infection (HCV) and may face unique barriers in receipt of HCV care. This study sought the …

Hepatitis C virus risk among young people who inject drugs

P Mateu-Gelabert, NS Sabounchi, H Guarino… - Frontiers in Public …, 2022 - frontiersin.org
Background Injection drug use (IDU) is the leading risk factor for hepatitis C virus (HCV)
transmission in the US While the general risk factors for HCV transmission are known, there …

[HTML][HTML] Elimination of HCV Infection: Recent Epidemiological Findings, Barriers, and Strategies for the Coming Years

P Torre, M Festa, T Sarcina, M Masarone, M Persico - Viruses, 2024 - mdpi.com
Hepatitis C is a disease for which in approximately 30 years we have gone from the
discovery of the causative agent in 1989, to the introduction of direct-acting antiviral (DAAs) …

Trends and distinct profiles of persons who inject drugs in the United States, 2015–2019

D Park, S Oh, M Cano, CP Salas-Wright, MG Vaughn - Preventive Medicine, 2022 - Elsevier
Drug injection represents a major health problem in the US, with severe health
consequences including the transmission of blood-borne infections. An examination of the …

Drug use-related stigma, safer injection norms, and hepatitis C infection among a network-based sample of young people who inject drugs

LD Williams, ME Mackesy-Amiti, C Latkin… - Drug and alcohol …, 2021 - Elsevier
Background Identifying risk for hepatitis C (HCV) infection is important for understanding
recent increases in HCV incidence among young people who inject drugs (PWID) in …